Literature DB >> 6611346

T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls.

L Si, T L Whiteside, R R Schade, T E Starzl, D H Van Thiel.   

Abstract

T lymphocytes infiltrating hepatic tissues were typed and enumerated in liver biopsies of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls using monoclonal antibodies and the avidin-biotin-immunoperoxidase technique. The peripheral blood mononuclear cells were studied also by flow cytometry. In PBC, T lymphocytes were decreased (P less than 0.001) in the blood [absolute number was 426 +/- 200 (SE) vs 1351 +/- 416 in 15 controls], as was the helper/suppressor (T4/T8) ratio (1.0 +/- 0.1 vs normal 2.3 +/- 0.3). T lymphocytes were the most numerous mononuclear cells infiltrating portal areas of PBC livers: 749 +/- 93/5 high-power fields (HPF) in PBC vs 98 +/- 15/5 HPF (P less than 0.01) in controls. The T4/T8 ratios varied from 0.9 to 2.3 (mean, 1.8 +/- 0.1) in the portal triads (normal mean, 1.6 +/- 0.1), with the T4+ cells accounting for more than 75% of infiltrating T cells. In contrast, the mean T4/T8 ratio in portal triads of PSC was reduced (1.0 +/- 0.3) due to a significant increase (P less than 0.001) in the number of T8+ cells. The T cells around and in the walls of bile ducts in PBC were mostly T8+, and the T4/T8 ratio was 0.8 +/- 0.2. No T8+ cells were seen in this location in PSC and normal livers. Few mononuclear cells were present in hepatic lobules. Subtyping of T lymphocytes in liver tissues of patients with PBC and PSC may be helpful in the differential pathologic diagnosis. In patients with advanced PBC, a decrease in T4+ cells in the blood appeared to be accompanied by their accumulation in the portal triads. In contrast, T8+ cells accumulated preferentially around bile ducts.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611346      PMCID: PMC3095831          DOI: 10.1007/bf00915293

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  25 in total

1.  The presentation and diagnosis of 100 patients with primary biliary cirrhosis.

Authors:  S Sherlock; P J Scheuer
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

2.  Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis.

Authors:  P L Golding; M Smith; R Williams
Journal:  Am J Med       Date:  1973-12       Impact factor: 4.965

3.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

4.  Suppressor cell activity in primary biliary cirrhosis.

Authors:  R K Zetterman; J A Woltjen
Journal:  Dig Dis Sci       Date:  1980-02       Impact factor: 3.199

5.  Immune complexes in acute and chronic liver disease.

Authors:  H C Thomas; D De Villiers; B Potter; H Hodgson; S Jain; D P Jewell; S Sherlock
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

6.  Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome.

Authors:  A P Geubel; R H Keller; W H Summerskill; E R Dickson; T B Tomasi; R G Shorter
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

7.  Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.

Authors:  F Paronetto; S Vernace
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

8.  Lymphocyte populations in liver biopsy specimens from patients with chronic liver disease.

Authors:  J Sanchez-Tapias; H C Thomas; S Sherlock
Journal:  Gut       Date:  1977-06       Impact factor: 23.059

9.  Lymphocyte subpopulations at the site of "piecemeal" necrosis in end stage chronic liver diseases and rejecting liver allografts in cyclosporine-treated patients.

Authors:  L Si; T L Whiteside; D H Van Thiel; B S Rabin
Journal:  Lab Invest       Date:  1984-03       Impact factor: 5.662

10.  Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases.

Authors:  I G McFarlane; B M Wojcicka; D C Tsantoulas; B C Portmann; A L Eddleston; R Williams
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

View more
  19 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  The effect of recombinant interferon-alpha on lymphocyte subpopulations and HLA-DR expression on liver tissue of HBV-positive individuals.

Authors:  Y K Yoo; J B Gavaler; K Chen; T L Whiteside; D H van Thiel
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

Review 3.  Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens.

Authors:  I R Mackay; M E Gershwin
Journal:  Springer Semin Immunopathol       Date:  1990

Review 4.  Primary biliary cirrhosis: new perspectives.

Authors:  W C Maddrey
Journal:  Trans Am Clin Climatol Assoc       Date:  1989

5.  Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH).

Authors:  L S Si; T L Whiteside; R R Schade; D H Van Thiel
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

6.  Phenotypic characterization of mononuclear infiltrate present in liver of biliary atresia.

Authors:  K Chen; J S Gavaler; D H Van Thiel; T Whiteside
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

7.  S100 protein positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases. Relevance to pathogenesis?

Authors:  A J Demetris; C Sever; S Kakizoe; S Oguma; T E Starzl; R Jaffe
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

8.  Primary biliary cirrhosis presenting with granulomatous skin lesions.

Authors:  D L Jardine; S T Chambers; D J Hart; B A Chapman
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

9.  Induction of DR/IA antigens in human liver allografts. An immunocytochemical and clinicopathologic analysis of twenty failed grafts.

Authors:  A J Demetris; S Lasky; D H Van Thiel; T E Starzl; T Whiteside
Journal:  Transplantation       Date:  1985-11       Impact factor: 4.939

Review 10.  The immunobiology of primary sclerosing cholangitis.

Authors:  Jonathan H Aron; Christopher L Bowlus
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.